Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
P-MUC1C-ALLO1 by Poseida Therapeutics for Pancreatic Cancer: Likelihood of Approval
P-MUC1C-ALLO1 is under clinical development by Poseida Therapeutics and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...
P-MUC1C-ALLO1 by Poseida Therapeutics for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
P-MUC1C-ALLO1 is under clinical development by Poseida Therapeutics and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According to...
P-MUC1C-ALLO1 by Poseida Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
P-MUC1C-ALLO1 is under clinical development by Poseida Therapeutics and currently in Phase I for Non-Small Cell Lung Cancer. According to...